REGENERON PHARMACEUTICALS

REGNNASDAQ

🏆 #166 by market capEarnings Oct 26Biotech

$797.00▼ $10.92 (−1.37%)

Live

1h—

24h▼ 1.4%

7d—

14d—

30d—

1y—

🏦Market Cap

$83.56B

Mid Cap

📈Revenue Growth (YoY)

+9.3%

Slowing

📊Gross Margin

86.0%

High

💵FCF Margin

23.0%

Strong

⚖️P/S Ratio

5.3x

Fair

Otter Score

59

Weak

Earnings

Q3 · 2026Reported 2026-07-30

Earnings Per Share

Actual

14.29

Expected

10.16

beat

+40.60%

YoY +10.90%

Revenue

Actual

$4.29B

Expected

$3.82B

beat

+12.40%

YoY +16.70%

Consensus estimates

Recent quarters

Q3 2026

14.29

beat

Q2 2026

9.47

beat

Q1 2026

11.44

beat

Q4 2025

11.83

beat